Cadila Healthcare’s Topical manufacturing facility successfully completes USFDA inspection

07 Apr 2017 Evaluate

Cadila Healthcare’s Topical manufacturing located at Changodar was successfully inspected by US Food & Drug Administration (USFDA) from April 3 to April 7, 2017. At the end of the inspection, no observation (483) is issued. The company has filed 17 products with the USFDA from this manufacturing facility.

Cadila Healthcare is part of the Zydus Cadila Group. The company operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world.

Zydus Lifesciences Share Price

997.25 12.50 (1.27%)
15-May-2024 09:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1540.85
Dr. Reddys Lab 5920.85
Cipla 1400.80
Zydus Lifesciences 997.25
Lupin 1648.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.